Study: Denying anti-depressants for teens, young adults raises risk of suicides
Government warnings a decade ago about the risks associated with children and adolescents taking anti-depressants, such as Paxil and Zoloft, appear to have backfired — causing an increase in suicide attempts and discouraging many depressed young people from seeking treatment, according to a study published on Wednesday.
Because of FDA warnings about SSRIs — selective serotonin reuptake inhibitors — anti-depressant prescriptions fell sharply for adolescents ages 10 to 17 and for young adults ages 18 to 29. At the same time, researchers found that the number of suicide attempts rose by more than 20 percent in adolescents and by more than a third in young adults.
Show commenting policy
TribLive commenting policy
- Obama wants to end U.S. companies skirting tax laws by merging with overseas entities
- Scientists: Earth in midst of 6th ‘mass extinction’
- After 40 years, Wyo. fossil trove to get another look
- U.N. school in Gaza shelled; 15 Palestinian civilians killed, many children wounded
- Warrant issued in Calif. for tuberculosis patient
- Outcry saves rare albino-mix redwood in Calif.
- Feathered dinosaur fossil found
- Russia firing into Ukraine, U.S. intel finds
- Social Security’s $300M IT project doesn’t work
- American kids have false idea of their weight status, CDC says
- Glenn Beck takes on Common Core